Immunofoco, a company dedicated to advancing cell therapies for solid tumors, announced that its independently developed, innovative lentiviral vector-based In Vivo CAR-T Technology Platform made a ...

Research from Vibrant Sciences, confirming high sensitivity and broad pathogen coverage using low-volume antibody testing, published in Nature SANTA CLARA, CA / ACCESS Newswire / May 13, 2025 / A new ...